Doximity, Inc.

NYSE:DOCS Stock Report

Market Cap: US$11.0b

Doximity Past Earnings Performance

Past criteria checks 5/6

Doximity has been growing earnings at an average annual rate of 35.3%, while the Healthcare Services industry saw earnings growing at 23.3% annually. Revenues have been growing at an average rate of 17.8% per year. Doximity's return on equity is 18.1%, and it has net margins of 33.7%.

Key information

35.3%

Earnings growth rate

23.0%

EPS growth rate

Healthcare Services Industry Growth1.7%
Revenue growth rate17.8%
Return on equity18.1%
Net Margin33.7%
Next Earnings Update06 Feb 2025

Recent past performance updates

Recent updates

When Should You Buy Doximity, Inc. (NYSE:DOCS)?

Jan 24
When Should You Buy Doximity, Inc. (NYSE:DOCS)?

Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution

Jan 13

Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching

Jan 06
Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching

Doximity: Strong Fundamentals And Growth Potential Makes It Attractive

Dec 06

Doximity (NYSE:DOCS) Knows How To Allocate Capital

Dec 01
Doximity (NYSE:DOCS) Knows How To Allocate Capital

Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%

Nov 13
Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%

Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?

Nov 02
Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?

Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Oct 15
Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Doximity: Downgrade To Hold On Valuation Concerns

Oct 03

Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors

Sep 23
Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors

There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump

Aug 18
There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump

Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns

Aug 10
Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns

Doximity Faces Slower Revenue Growth As R&D Costs May Rise

Jul 23

Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?

Jul 23
Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?

At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?

Jul 01
At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?

Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Jun 09
Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)

May 17

Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

May 04
Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

Doximity: Significant Upside Remains, But Not Until The Growth Story Returns

Apr 29

With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Apr 16
With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Mar 26
Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: Rating Upgrade To Buy As Outlook Turns Positive

Feb 21

We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

Feb 15
We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Feb 13
What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan

Jan 16

Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism

Nov 10

Doximity: Adding Value Using AI But Faces Near-Term Risks

Nov 01

Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook

Aug 24

Doximity Earnings: Too Many Problems, Sell

Aug 09

Doximity: Continue To See Positive Upside From Current Stock Level

Jul 05

Doximity: Digital Health Play With Strong Fundamentals

Jun 21

Revenue & Expenses Breakdown

How Doximity makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:DOCS Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2451717417686
30 Jun 2449416117183
31 Mar 2447514817082
31 Dec 2346813816983
30 Sep 2344812316784
30 Jun 2343711916683
31 Mar 2341911316080
31 Dec 2240211915376
30 Sep 2238414114672
30 Jun 2236214813868
31 Mar 2234413312862
31 Dec 2131710711457
30 Sep 212775710153
30 Jun 21243308847
31 Mar 21207227844
31 Dec 20177146740
31 Mar 20116114632
31 Mar 198614027

Quality Earnings: DOCS has high quality earnings.

Growing Profit Margin: DOCS's current net profit margins (33.7%) are higher than last year (27.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: DOCS's earnings have grown significantly by 35.3% per year over the past 5 years.

Accelerating Growth: DOCS's earnings growth over the past year (41.4%) exceeds its 5-year average (35.3% per year).

Earnings vs Industry: DOCS earnings growth over the past year (41.4%) exceeded the Healthcare Services industry 17.5%.

Return on Equity

High ROE: DOCS's Return on Equity (18.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 23:30
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Doximity, Inc. is covered by 26 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vikram KesavabhotlaBaird
Nisala WeerasuriyaBerenberg
Allen LutzBofA Global Research